Docmode Health Technologies share price
NSE: DHTLOther Consumer Services
Docmode Health Technologies Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2024 · Issue price ₹79
Last close ₹22.05up ₹0.05 (0.23%)
Share price at the NSE close on 27 Oct 2026. Previous close ₹22.00.
27 Oct: open ₹21.90, high ₹22.05, low ₹21.90
52-week range of traded prices to 27 Oct 2026
₹21.90Low, 27 Oct 2026₹125.20High, 3 Nov 2025
- Under NSE's long-term additional surveillance, stage I, on the list for 27 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹6.93 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.84
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −1.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,600100.0% delivered
Results
Consolidated; ₹ crore.Docmode Health Technologies half-yearly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- −38.9%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- –
Half year to Mar 2026, against the half year before
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹7.67 Crdown 57.03%
- Net profitNet profit. Under it, net profit in the half year before. A change in per cent is not worked out where either period is a loss or nothing. Net profit in the glossary
- −₹0.07 CrHalf year to Sep 2025: −₹0.09 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- −0.9%
Revenue by half year
Peak revenue ₹24 Cr, half year to Sep 2023; lowest ₹7.67 Cr, half year to Mar 2026
Net profit by half year, a loss in red
- Net profit
- Loss
A loss in 5 of the 6 half years shown
| ₹ crore | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | 23.6 | 16.4 | 20.4 | 21.4 | 17.8 | 7.7 |
| Net profit | 1.4 | −1.2 | −0.5 | −1.4 | −0.1 | −0.1 |
| Net margin | 5.8% | −7.1% | −2.6% | −6.4% | −0.5% | −0.9% |
Consolidated. The 6 half years from Sep 2023, the first on record. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹26 Crdown 38.92%
- Net profitNet profit. Under it, net profit in the year before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹0.14 CrYear to Mar 2025: −₹2.03 Cr
- Net margin
- −0.6%
Revenue by year
Peak revenue ₹42 Cr, year to Mar 2025; lowest ₹26 Cr, year to Mar 2026
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 2 of the 3 years shown
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 40.0 | 41.8 | 25.5 |
| Net profit | 0.2 | −2.0 | −0.1 |
| Net margin | 0.5% | −4.9% | −0.6% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −18.2% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Docmode Health Technologies insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 1 pledge invoked by a lender
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Docmode Health Technologies competitors and peers
Other Consumer Services, 49 listed companies, priced on 27 Oct 2026. The table lists the 8 companies closest to Docmode Health Technologies in market cap. 4 companies in the table last traded before then: their rows are priced on their last trade.Consumer services companies
Docmode Health Technologies is not on the chart: it has no P/E today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Mopshop DistributionMOPSHOP | 19 | – | – | – | – | – | – | 0.00% |
| Humming Bird EducationHBEL | 17 | 31.34 | 6.05 | +26.3% | −0.1% | 21.4% | – | 0.00% |
 Thinking Hats Entertainment SolutionsTHESL | 13 | 10.49 | 0.45 | −50.7% | −66.1% | 4.4% | – | 0.00% |
 MT EducareMTEDUCARE | 11 | – | – | – | – | – | – | 0.00% |
 Asian WarehousingASIAN | 11 | 42.29 | 0.43 | −12.1% | – | 1.0% | 2.5% | 0.00% |
 Usha Martin Education & SolutionsUMESLTD | 11 | – | 4.54 | +57.9% | – | – | 16.4% | 0.00% |
 Educomp SolutionsEDUCOMP | 11 | – | – | – | – | – | – | 0.00% |
| ACE EdutrendACEEDU | 3 | – | 0.43 | – | – | – | −0.6% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Docmode Health Technologies announcements
Oct 2026
Docmode Health Technologies share price by year
Each calendar year to 2025.Docmode Health Technologies share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 71.30 | −19.3% | 122.75 | 39.65 |
| 2024 | 88.35 | – | 278.00 | 81.80 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2024 is from its first session, 2 Feb 2024.
Recent sessions
The 9 trading days to 22 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 22 Oct 2026 | 22.00 | 22.00 | 22.00 | 22.00 | 22.00 | 800 | 100.0% |
| 14 Oct 2026 | 22.00 | 22.30 | 22.00 | 22.30 | 22.15 | 1,600 | 50.0% |
| 9 Oct 2026 | 23.00 | 23.45 | 22.35 | 22.35 | 22.70 | 4,000 | 60.0% |
| 7 Oct 2026 | 23.50 | 23.50 | 23.50 | 23.50 | 23.50 | 16,000 | 100.0% |
| 6 Oct 2026 | 24.75 | 24.75 | 23.55 | 23.55 | 24.27 | 28,000 | 88.6% |
| 5 Oct 2026 | 23.70 | 24.75 | 23.70 | 24.75 | 24.16 | 38,400 | 97.9% |
| 1 Oct 2026 | 24.90 | 24.95 | 23.75 | 23.75 | 24.87 | 48,800 | 93.4% |
| 30 Sep 2026 | 25.75 | 26.00 | 24.95 | 24.95 | 25.88 | 81,600 | 79.4% |
| 29 Sep 2026 | 25.75 | 26.25 | 25.75 | 26.25 | 26.00 | 30,400 | 50.0% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- DHTL
- ISIN
- INE0OGG01015
- Industry
- Other Consumer Services